Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upadacitinib”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Not applicableLooking for participantsNCT06581042
What this trial is testing

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

Who this might be right for
Ulcerative ColitisCrohn's Disease
AbbVie 280
Large-scale testing (Phase 3)Study completedNCT04169373
What this trial is testing

Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

Who this might be right for
Spondyloarthritis
AbbVie 734
Not applicableLooking for participantsNCT06630715
What this trial is testing

Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis (RAPsoriatic Arthritis (PsA
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 178
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156
What this trial is testing

Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

Who this might be right for
JAK1 GOFSTAT1 GOFSTAT3 GOF+2 more
Lisa Satter 30
Post-approval studies (Phase 4)Active Not RecruitingNCT07773623
What this trial is testing

An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis

Who this might be right for
Uveitis
Tianjin Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492251
What this trial is testing

Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.

Who this might be right for
Lichen Penis Planus
Centre Hospitalier Universitaire de Nice 56
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Very early researchLooking for participantsNCT06684522
What this trial is testing

Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis

Who this might be right for
Eyelid Dermatitis
Northwestern University 10
Large-scale testing (Phase 3)Study completedNCT05601882
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 920
Post-approval studies (Phase 4)Looking for participantsNCT07550673
What this trial is testing

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

Who this might be right for
Acute Severe Ulcerative Colitis
Xijing Hospital of Digestive Diseases 226
Post-approval studies (Phase 4)Not Yet RecruitingNCT07502339
What this trial is testing

Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis

Who this might be right for
UC - Ulcerative Colitis
University of California, San Francisco 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06118411
What this trial is testing

Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

Who this might be right for
Vitiligo
AbbVie 614
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Not applicableNot Yet RecruitingNCT07354906
What this trial is testing

Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

Who this might be right for
Giant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil 80
Not applicableActive Not RecruitingNCT05496348
What this trial is testing

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 400
Not applicableStudy completedNCT04574492
What this trial is testing

Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 413
Not applicableLooking for participantsNCT07073079
What this trial is testing

Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

Who this might be right for
Crohn's Disease
AbbVie 250
Large-scale testing (Phase 3)Active Not RecruitingNCT07008846
What this trial is testing

Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 96
Post-approval studies (Phase 4)Study completedNCT05507580
What this trial is testing

Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 461
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Next Page